Tuberculosis infection in rheumatic patients with infliximab therapy: Experience with 157 patients

Rheumatology International

Volumn 32, Issue 9, 2012, Pages 2769-2775

  Nobre, Christiane Aguiar ^a   Callado, Maria Roseli Monteiro ^a   Lima, José Rubens Costa ^a   Gomes, Kirla Wagner Poti ^a  

^a HOSPITAL GERAL DE FORTALEZA   (Brazil)

Author keywords

Ankylosing spondylitis; Infliximab; Psoriatic arthritis; Rheumatoid arthritis; Tuberculosis

Indexed keywords

INFLIXIMAB; ISONIAZID; TUBERCULIN;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DRUG EFFICACY; ENDEMIC DISEASE; FEMALE; HUMAN; IMMUNOPROPHYLAXIS; IMMUNOREACTIVITY; INTERVERTEBRAL DISK DEGENERATION; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; THORAX RADIOGRAPHY; TREATMENT RESPONSE; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ANTITUBERCULAR AGENTS; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; BRAZIL; COMORBIDITY; FEMALE; HUMANS; ISONIAZID; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RHEUMATIC DISEASES; SPONDYLITIS, ANKYLOSING; TUBERCULIN; TUBERCULIN TEST; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84866356233     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2017-5     Document Type: Article

References (32)

1. Keane J, Gershon S, Wise RP et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345:1098-1104
2. Ormerod LP, Milburn HJ, Gillespie S, Ledingham J, Rampton D (2005) BTS recommendations for assessing risk and managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNFa treatment. Thorax 60:800-805 (Pubitemid 41475202)
3. Hanta I, Ozbek S, Kuleci S, Kocabas A (2008) The evaluation of latent tuberculosis in rheumatologic diseases for anti-TNF therapy: experience with 192 patients. Clin Rheumatol 27:1083-1086
4. Ministério da Saúde (2010) Programa Nacional de Controle da Tuberculose-Manual de Recomendaçoes para o Controle da Tuberculose no Brasil. http://portal.saude.gov.br/portal/arquivos/pdf/manual-de-recomendacoes- controle-tb-novo.pdf. Accessed 06 Oct 2010
5. Ehrenstein MR, Evans JG, Singh A et al (2004) Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF-a therapy. J Exp Med 200:277-285 (Pubitemid 39031247)
6. Ponce de León D, Acevedo-Vásquez E, Sánchez-Torres A et al (2005) Attenuated response to purified protein derivate in patients with rheumatoid arthritis: study in a population with high prevalence of tuberculosis. Ann Rheum Dis 64:1360-1361 (Pubitemid 41206259)
7. Filho AC, Kritski AL, Barreto AW et al (2004) II Consenso brasileiro de tuberculose. Diretrizes brasileiras para tuberculose. J Bras Pneumol 30(1):1-55
8. Façanha MC, Guerreiro MFF, Pinheiro AC et al (2003) Resgate de casos subnotificados de tuberculose em Fortaleza-CE, 2000-2002. Bol Pneumol Sanit 11(2):13-16
9. Seong SS, Choi CB, Woo JH et al (2007) Incidence of tuberculosis in Korean patients with rheumatoid arthritis itself and tumor necrosis factor blocks. J Rhematol 34:706-711
10. Silva JB Jr (2004) Tuberculose: Guia de Vigilância Epidemiolo ́gica. J Bras Pneumol 30:57-85
11. Gomez-Reino JJ, Carmona L, Descalzo A, BIOBADASER GROUP (2007) Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis Rheum 57(5): 756-761 (Pubitemid 46932080)
12. Panayi G, Corrigal V, Pitzalis C (2001) Pathogenesis of rheumatoid arthritis. The role of cells and others beasts. Rheum Dis Clin North Am 161:221-247
13. Corrigal VM, Garyfallos A, Panayi GS (1999) The relative proportions of secreted interleukin-2 and interleukin-10 determine the magnitude of rheumatoid arthritis T-cell proliferations to the recall antigen tuberculin purified protein derivative. Rheumatology 38:1203-1207
14. Emery P, Panayi G, Symmons D, Brown G (1984) Mechanisms of depressed delayed-type hypersensitivity in rheumatoid arthritis: the role of protein energy malnutrition. Ann Rheum Dis 43:430-434 (Pubitemid 14117918)
15. Kingsley GH, Pitzalis C, Panay GS (1987) Abnormal lymphocyte reactivity to self-major histocompatibility antigens in rheumatoid arthritis. J Rheumatol 14:667-673
16. Marques CDL, Duarte ALBP, Lorena VMB et al (2009) Resposta atenuada ao PPD no diagnóstico de infecçao tuberculosa latente em pacientes com artrite reumatóide. Rev Bras Reumatol 49(2): 121-131
17. Laurindo IMM, Seiscento M, Bombardia S et al (2004) Diagnosis of latent tuberculosis in rheumatoid arthritis (RA) patients: tuberculin test (PPD) assessment. EULAR, Rheumatoid arthritis clinical aspects [THU0235]. http://www.abstracts2view.com/eular/sessionindex.phpsession=2004374day=2004. Accessed 27 Jan 2010
18. Andrade TCB, Maia RM, Cosgrove C, Castelo Branco LRR (2005) BCG Moreau Rio de Janeiro-An oral vaccine against tuberculosis-review. Men Inst Oswaldo Cruz 100(5):459-465 (Pubitemid 41430288)
19. Maciel ELN, Viana MC, Zeitoune RCG, Ferreira I, Fregona G, Dietze R (2005) Prevalence and incidence of Mycobacterium tuberculosis infection in nursing students in Vitória, Esṕrito Santo. Rev Soc Bras Med Trop 38(6):469-472 (Pubitemid 43169980)
20. Pilsczek FH, Kaufmann SHE (2008) Prevalence and predictors of positive tuberculin skin test results in a research laboratory. Rev Soc Bras Med Trop 41(4):416-418
21. Köker IH, Pamuk Ö N, Karlikaya C, Tunçbilek N, Ç akir N (2007) A low prevalence of purified protein derivative test positivity in Turkish patients with rheumatoid arthritis. Association with clinical features and HRCT findings. Clin Exp Rheumatol 25: 54-59 (Pubitemid 46477486)
22. Pinheiro MM, Melo MR, Jennings MF, Barbosa CP, Terreri MT, Hilário MOE (2010) Positividade do teste tubercuĺnico em crianc ̧as e adultos com artropatias inflamatórias crônicas e indicaçao para o uso de terapia anti-TNF. Congresso Brasileiro de Reumatologia 2010, Artrite reumatóide/epidemiologia e aspectos cĺnicos. Rev Bras Reumatol 50(1):84
23. Pereira SM, Dantas OMS, Ximenes R, Barreto ML (2007) Vacina BCG contra tuberculose: efeito protetor e poĺticas de vacinaçao. Rev Saúde Pública 41(Supl. 1):59-66. http://www.scielosp.org/pdf/rsp/ v41s1/6492.pdf. Accessed 08 Oct 2010
24. Saito M, Bautista CT, Gilman RH, Bowering A, Levy MZ, Evans CA (2004) The value of counting BCG scars for interpretation of tuberculin skin tests in a tuberculosis hyperendemic shantytown, Peru. Int J Tuberc Lung Dis 8(7):842-847 (Pubitemid 38949792)
25. Provenzano G, Ferrante MC, Simon G (2005) TB screening and anti-TNF a treatment. Thorax 60:612-615
26. Sellam J, Hamdi H, Roy C et al (2007) Comparison of in vitrospeciWc blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy. Ann Rheum Dis. doi: 10.1136/ard.2007.069799 (Pubitemid 350205449)
27. Dheda K, Udwadia ZF, Huggett JF, Johnson MA, Rook GA (2005) Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis. Curr Opin Pulm Med 11(3): 195-202 (Pubitemid 40577168)
28. Marques CDL, Duarte ALBP, Lorena VMB et al (2009) Evaluation of an interferon gamma assay in the diagnosis of latent tuberculosis infection in patients with rheumatoid arthritis. Rheumatol Int 30:57-62
29. Montoro M, Gonzalez C, López-Longo FJ et al (2009) New PPDpositive test during infliximab treatment. ACR Annual meeting, Abstract 135. http://acr.confex.com/acr/2009/webprogram/paper 15520.html. Accessed 26 Nov 2010
30. Cush JJ, Winthrop K, Dao K et al (2010) ACR Safety Committee. Screening for Mycobacterium tuberculosis Infection: questions and answers for clinical practice. http://www.rheumatology.org/publications/dsq/dsq-2010-02.pdf. Accessed 26 Nov 2010
31. Cooray D, Moran R, Broumand A et al (2009) Serial re-screening in high risk patients on anti-TNF alpha therapy validate CDC recommendations of monitoring TB risk. ACR annual meeting, Abstract 1153. http://acr.confex.com/ acr/2009/webprogram/paper 15478.html. Accessed 26 Nov 2010
32. Fuchs I, Avnon L, Freud T, Abu-Shakra M (2009) Repeated tuberculin skin testing following therapy with TNF-alpha inhibitors. Clin Rheumatol 28(2):167-172